This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2003-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kensington, MD (US) (2003 - 2012)
- Szeged, HU (2017)
Company Filing History:
Years Active: 2003-2017
Title: Zoltan Olah: Innovator in Pain Management
Introduction
Zoltan Olah is a notable inventor based in Szeged, Hungary. He has made significant contributions to the field of pain management through his innovative research and inventions. With a total of 3 patents, Olah's work focuses on the selective ablation of pain-sensing neurons, which has implications for treating pain and inflammatory disorders.
Latest Patents
One of Olah's latest patents is titled "Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist." This invention provides methods and kits for the selective ablation of pain-sensing neurons. The methods involve administering a vanilloid receptor agonist to a ganglion in an amount that causes the death of vanilloid receptor-bearing neurons. This innovative approach offers new methods for controlling pain and inflammatory disorders that involve the activation of these neurons.
Career Highlights
Olah works for the United States of America, as represented by the Secretary, Department of Health and Human Services. His research has been pivotal in advancing the understanding of pain mechanisms and developing targeted therapies.
Collaborations
Throughout his career, Zoltan Olah has collaborated with esteemed colleagues, including Michael J. Iadarola and Laszlo Karai. These collaborations have further enriched his research and contributed to the development of effective pain management strategies.
Conclusion
Zoltan Olah's innovative work in the field of pain management highlights the importance of targeted therapies in treating pain and inflammatory disorders. His contributions continue to influence the medical community and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
